{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:17:41Z","timestamp":1783448261990,"version":"3.55.0"},"reference-count":41,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":424,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Patients with appendiceal neuroendocrine tumours (aNETs) have an excellent prognosis. Appendiceal goblet cell adenocarcinomas (aGCAs), formerly called goblet carcinoid, show overlapping features with aNETs. Many discrepancies exist between studies regarding prognostication of patients with aNETs. In this study, we aim to identify differences in disease course between aNETs and aGCAs to explain inconsistencies in the literature and identify variables influencing recurrence and survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with aNET or aGCA diagnosed between 2000 and 2019 were included. Kaplan\u2013Meier curves were performed in patients with aNET and aGCA independently and in a combined group covering both aNETs and aGCAs to assess progression-free survival (PFS) and disease-specific survival (DSS). Cox regression was used to identify variables influencing PFS and DSS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 122 patients were included: 92 with aNET and 30 with aGCA. Five- and 10-year PFS rates in patients with aNET were both 98%, whereas in patients with aGCA, this was 57% and 30%, respectively. The 5- and 10-year DSS rates for aNETs were 100 and 96%, and for aGCAs, this was 77 and 58%. In the combined group, 5- and 10-year DSS were 92 and 84%, and the presence of peritoneal metastases showed worse DSS (P &amp;lt; 0.001). WHO grade 3 was associated with poorer PFS (HR 18.68, 95% CI (2.24\u2013155.59), P = 0.007) and DSS (HR = 10.21, 95% CI (1.23\u201385.08), P = 0.032) in aGCAs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>aNETs and aGCAs are different entities with a distinct prognosis. Differences in DSS between aNETs and aGCAs indicate previous studies misclassified aggressive tumours as aNETs, which addresses the importance of accurate tumour registration and reckoning with changes in nomenclature.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/eo-25-0028","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T22:26:57Z","timestamp":1752877617000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-15","source":"Crossref","is-referenced-by-count":1,"title":["Survival and prognostic differences between appendiceal NETs and goblet cell adenocarcinomas"],"prefix":"10.1530","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3886-4655","authenticated-orcid":true,"given":"Kim","family":"Dijke","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Oncology, Netherlands Cancer Institute 1 , ,","place":["Amsterdam, The Netherlands"]},{"name":"Department of Endocrine Oncology, University Medical Centre Utrecht 2 , ,","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Netherlands Cancer Institute 3 , ,","place":["Amsterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koert F D","family":"Kuhlmann","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Netherlands Cancer Institute 4 , ,","place":["Amsterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Levy","sequence":"additional","affiliation":[{"name":"Department Medical Oncology, Netherlands Cancer Institute 5 , ,","place":["Amsterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlof D","family":"Valk","sequence":"additional","affiliation":[{"name":"Department of Endocrine Oncology, University Medical Centre Utrecht 2 , ,","place":["Utrecht, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot E T","family":"Tesselaar","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Oncology, Netherlands Cancer Institute 1 , ,","place":["Amsterdam, The Netherlands"]},{"name":"Department Medical Oncology, Netherlands Cancer Institute 5 , ,","place":["Amsterdam, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"2026070713303829000_bib1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1007\/s12020-021-02727-9","article-title":"Appendiceal goblet cell carcinomas have poor survival despite completion surgery","volume":"73","author":"Alabraba","year":"2021","journal-title":"Endocrine"},{"key":"2026070713303829000_bib2","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ejso.2020.09.012","article-title":"The impact of lymph node metastases and right hemicolectomy on outcomes in appendiceal neuroendocrine tumours (aNETs)","volume":"47","author":"Alabraba","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2026070713303829000_bib3","doi-asserted-by":"crossref","first-page":"664","DOI":"10.5858\/arpa.2019-0665-RA","article-title":"What is new in the 2019 World Health Organization (WHO) classification of tumors of the digestive system: review of selected updates on neuroendocrine neoplasms, appendiceal tumors, and molecular testing","volume":"145","author":"Assarzadegan","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"2026070713303829000_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4030527","article-title":"Appendix neuroendocrine tumor: retrospective analysis of 4026 appendectomy patients in a single center","volume":"2020","author":"Bayhan","year":"2020","journal-title":"Emerg Med Int"},{"key":"2026070713303829000_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.humpath.2022.06.002","article-title":"Goblet cell adenocarcinoma of the appendix: an update and practical approach to diagnosis and grading","volume":"132","author":"Bell","year":"2022","journal-title":"Hum Pathol"},{"key":"2026070713303829000_bib6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.ejso.2010.05.025","article-title":"Primary appendiceal carcinoma \u2013 epidemiology, surgery and survival: results of a German multi-center study","volume":"36","author":"Benedix","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"2026070713303829000_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","article-title":"The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors well-differentiated; neuroendocrine tumors of the jejunum, ileum, appendix, and cecum","volume":"39","author":"Boudreaux","year":"2010","journal-title":"Pancreas"},{"key":"2026070713303829000_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/SLA.0000000000002939","article-title":"Morphological factors related to nodal metastases in neuroendocrine tumors of the appendix: a multicentric retrospective study","volume":"271","author":"Brighi","year":"2020","journal-title":"Ann Surg"},{"key":"2026070713303829000_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"2026070713303829000_bib10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026070713303829000_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jso.21764","article-title":"Appendiceal carcinoid tumors: predictors of lymph node metastasis and the impact of right hemicolectomy on survival","volume":"103","author":"Groth","year":"2011","journal-title":"J Surg Oncol"},{"key":"2026070713303829000_bib12","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1245\/s10434-024-14892-y","article-title":"AJCC cancer staging system version 9: appendiceal adenocarcinoma","volume":"31","author":"Hanna","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"2026070713303829000_bib13","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/cncr.23883","article-title":"Neuroendocrine tumor epidemiology: contrasting Norway and North America","volume":"113","author":"Hauso","year":"2008","journal-title":"Cancer"},{"key":"2026070713303829000_bib14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ejso.2021.02.005","article-title":"Neuroendocrine neoplasms of the appendix: characterization of 335 patients referred to the copenhagen NET center of excellence","volume":"47","author":"Holmager","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2026070713303829000_bib15","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s11605-008-0545-4","article-title":"Carcinoid tumour of the appendix: an analysis of 1,485 consecutive emergency appendectomies","volume":"12","author":"In\u2019t Hof","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"2026070713303829000_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13332","article-title":"European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for appendiceal neuroendocrine tumours (aNET)","volume":"35","author":"Kaltsas","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"2026070713303829000_bib17","doi-asserted-by":"crossref","first-page":"8916","DOI":"10.1245\/s10434-021-10191-y","article-title":"Omission of right hemicolectomy may be safe for some appendiceal goblet cell adenocarcinomas: a survival analysis of the national cancer database","volume":"28","author":"Kowalsky","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2026070713303829000_bib18","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000440725","article-title":"Appendiceal goblet cell carcinoids: management considerations from a reference peritoneal tumour service centre and ENETS centre of excellence","volume":"103","author":"Lamarca","year":"2016","journal-title":"Neuroendocrinology"},{"key":"2026070713303829000_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1245\/s10434-020-08748-4","article-title":"Management of appendiceal neuroendocrine tumors: metastatic potential of small tumors","volume":"28","author":"Landry","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2026070713303829000_bib20","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.humpath.2015.08.005","article-title":"Simplified 2-tier histologic grading system accurately predicts outcomes in goblet cell carcinoid of the appendix","volume":"46","author":"Lee","year":"2015","journal-title":"Hum Pathol"},{"key":"2026070713303829000_bib21","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1245\/s10434-016-5734-x","article-title":"Peritoneal metastases from gastroenteropancreatic neuroendocrine tumors: incidence, risk factors and prognosis","volume":"24","author":"Madani","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"2026070713303829000_bib22","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/cncr.10589","article-title":"Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998","volume":"94","author":"McCusker","year":"2002","journal-title":"Cancer"},{"key":"2026070713303829000_bib23","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1007\/s10350-005-0196-4","article-title":"Malignancies of the appendix: beyond case series reports","volume":"48","author":"McGory","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"2026070713303829000_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jso.21888","article-title":"Carcinoid tumors of the appendix: a population-based study","volume":"104","author":"Mullen","year":"2011","journal-title":"J Surg Oncol"},{"key":"2026070713303829000_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(22)00750-1","article-title":"Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1\u20132 Cm in size: a retrospective, Europe-wide, pooled cohort study","volume":"24","author":"Nesti","year":"2023","journal-title":"Lancet Oncol"},{"key":"2026070713303829000_bib26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000478742","article-title":"Surgical managment of patients with neuroendocrine neoplasms of the appendix: appendectomy or more","volume":"106","author":"Nikhil","year":"2018","journal-title":"Neuroendocrinology"},{"key":"2026070713303829000_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.humpath.2017.08.005","article-title":"A study of appendiceal crypt cell adenocarcinoma (so-called goblet cell carcinoid and its related adenocarcinoma)","volume":"72","author":"Nonaka","year":"2018","journal-title":"Hum Pathol"},{"key":"2026070713303829000_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.915028","article-title":"Goblet cell adenocarcinoma of the appendix: a systematic review and incidence and survival of 1,225 cases from an English cancer registry","volume":"12","author":"Palmer","year":"2022","journal-title":"Front Oncol"},{"key":"2026070713303829000_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000335629","article-title":"ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas","volume":"95","author":"Pape","year":"2012","journal-title":"Neuroendocrinology"},{"key":"2026070713303829000_bib30","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443165","article-title":"ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas)","volume":"103","author":"Pape","year":"2016","journal-title":"Neuroendocrinology"},{"key":"2026070713303829000_bib31","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1023\/A:1012272314550","article-title":"Epidemiology and survival in patients with carcinoid disease in the Netherlands. An epidemiological study with 2391 patients","volume":"12","author":"Quaedvlieg","year":"2001","journal-title":"Ann Oncol"},{"key":"2026070713303829000_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026070713303829000_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1572-0241.1998.00422.x","article-title":"A retrospective analysis of 1570 appendiceal carcinoids","volume":"93","author":"Sandor","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"2026070713303829000_bib34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.4143\/crt.2015.029","article-title":"Appendiceal neuroendocrine, goblet and signet-ring cell tumors: a spectrum of diseases with different patterns of presentation and outcome","volume":"48","author":"Shaib","year":"2016","journal-title":"Cancer Res Treat"},{"key":"2026070713303829000_bib35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/his.14189","article-title":"Clinicopathological analysis of appendiceal goblet cell adenocarcinoma with peritoneal metastasis: World Health Organization grade predicts survival following cytoreductive surgery with intraperitoneal chemotherapy","volume":"77","author":"Shyu","year":"2020","journal-title":"Histopathology"},{"key":"2026070713303829000_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13329","article-title":"Clinical features and outcomes of appendiceal neuroendocrine tumours: 10 year audit from the Irish NET centre of excellence","volume":"35","author":"Storan","year":"2023","journal-title":"J Neuroendocrinol"},{"key":"2026070713303829000_bib37","doi-asserted-by":"crossref","first-page":"782","DOI":"10.5858\/arpa.2013-0047-OA","article-title":"Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis","volume":"139","author":"Taggart","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"2026070713303829000_bib38","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0b013e31817f1816","article-title":"Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix","volume":"32","author":"Tang","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"2026070713303829000_bib39","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1245\/s10434-018-6560-0","article-title":"Outcomes of surgical and chemotherapeutic treatments of goblet cell carcinoid tumors of the appendix","volume":"25","author":"Tsang","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"2026070713303829000_bib40","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1245\/s10434-012-2238-1","article-title":"Importance of histologic subtype in the staging of appendiceal tumors","volume":"19","author":"Turaga","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"2026070713303829000_bib41","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.amjsurg.2020.09.021","article-title":"Temporal trends in incidence, evaluation and management of neuroendocrine neoplasms of the appendix: 14 years' experience","volume":"221","author":"Twito","year":"2021","journal-title":"Am J Surg"}],"container-title":["Endocrine Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eo.bioscientifica.com\/view\/journals\/eo\/5\/1\/EO-25-0028.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eo.bioscientifica.com\/downloadpdf\/journals\/eo\/5\/1\/EO-25-0028.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article-pdf\/doi\/10.1530\/EO-25-0028\/195902\/eo-25-0028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article-pdf\/doi\/10.1530\/EO-25-0028\/195902\/eo-25-0028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:51:48Z","timestamp":1783446708000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article\/5\/1\/e250028\/35007\/Survival-and-prognostic-differences-between"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eo-25-0028","relation":{},"ISSN":["2634-4793"],"issn-type":[{"value":"2634-4793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"e250028"}}